| ₹ crore | Q1 FY27 | Year before | Change |
|---|---|---|---|
| Revenue | 257 | — | — |
| EBITDA | 40.3 | — | — |
| EBITDA margin | 15.7% | — | — |
| Profit before tax | −8.6 | — | — |
| Net profit | −9.6 | — | — |
| EPS | −₹1.20 | — | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast close | FY26Mar 2026 |
|---|
| 4,131 | — | |
| 160 | 160 | |
| 44.7 | 44.7 | |
| 4,015 | — | |
| 735 | 735 | |
| 92.9 | 92.9 | |
| 12.6% | 12.6% | |
| 17.9 | 17.9 | |
| 52.4 | 52.4 | |
| 7.1% | 7.1% | |
| ₹6.60 | ₹6.60 | |
| 150 | 150 | |
| −39.4 | −39.4 | |
| 111 | 111 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY26 31/03/2026 | Current last close | |
|---|---|---|---|
| Market Capitalization | — | 4,131.0 | |
| - Cash, Equiv & ST Investments | 160.4 | 160.4 | |
| + Total Debt | 44.7 | 44.7 | |
| Enterprise Value | — | 4,015.3 | |
| Revenue | 734.6 | 734.6 | |
| EBITDA | 92.9 | 92.9 | |
| Margin % | 12.64 | 12.64 | |
| EBIT | 17.9 | 17.9 | |
| Net Income | 52.4 | 52.4 | |
| Margin % | 7.13 | 7.13 | |
| EPS, Adj (current shares) | 6.60 | 6.60 | |
| Cash from Operations | 149.9 | 149.9 | |
| Capital Expenditures | -39.4 | -39.4 | |
| Free Cash Flow | 110.5 | 110.5 | |
Prices at the previous close · figures from the company's filings with NSE
Capillary Technologies India (NSE: CAPILLARY) had a market capitalisation of ₹4,134 crore at the previous close (₹520.25 a share) and a price-to-book ratio of 4.04. In FY26 its consolidated net profit was ₹52.4 crore on revenue of ₹735 crore; in Q1 FY27 (April–June 2026) it was a loss of ₹9.6 crore. Its debt-to-equity ratio was 0.04 on 31 March 2026. Promoters held 47.23% of the shares on 30 September 2026.
Capillary Technologies India's price-to-book (PB) ratio is 4.04 at the previous close: a market capitalisation of ₹4,134 crore divided by shareholders' equity (book value) of ₹1,023 crore on 31 March 2026. That is a book value of ₹128.79 per share against a share price of ₹520.25.
Capillary Technologies India's net worth — shareholders' equity in its consolidated balance sheet — was ₹1,023 crore on 31 March 2026. Its market value is a different figure: a market capitalisation of ₹4,134 crore at the previous close.
On 30 September 2026, Capillary Technologies India's shares were held by promoters 47.23%, foreign portfolio investors (FII/FPI) 2.56%, domestic institutions (DII) 21.87% (including mutual funds at 16.19%) and retail and other non-institutional investors 28.33%.
Capillary Technologies India's market capitalisation was ₹4,134 crore at the previous close: 7.95 crore shares at ₹520.25 each.
Capillary Technologies India's debt-to-equity ratio was 0.04 on 31 March 2026: borrowings of ₹44.7 crore against total equity of ₹1,023 crore.
In FY26 (April 2025–March 2026), Capillary Technologies India's consolidated net profit was ₹52.4 crore, on revenue from operations of ₹735 crore.
No. Capillary Technologies India had borrowings of ₹44.7 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.04. Its cash and current investments were ₹484 crore, so it held net cash of ₹439 crore.
Capillary Technologies India's book value per share was ₹128.79 on 31 March 2026: shareholders' equity of ₹1,023 crore divided by the 7.95 crore shares in issue. The share price at the previous close was ₹520.25.
Promoters held 47.23% of Capillary Technologies India on 30 September 2026, down 4.22 percentage points from 51.45% the previous quarter, according to the shareholding pattern filed with NSE.
Capillary Technologies India's basic earnings per share (EPS) were ₹6.94 in FY26.
In FY26, Capillary Technologies India generated ₹150 crore of cash from operations and spent ₹39.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹111 crore.
Capillary Technologies India's latest results are for Q1 FY27 (April–June 2026), filed on 4 August 2026: consolidated net loss ₹9.6 crore; revenue from operations ₹257 crore.
Capillary Technologies India will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, the date of the board meeting it has notified to the exchanges.
On FY26 consolidated figures, against Rategain Travel Technologies and Tanla Platforms: Capillary Technologies India's operating margin of 2.4% is the lowest of the three (Rategain Travel Technologies 14.1%, Tanla Platforms 13.6%; peer average 13.9%).
In FY26, Capillary Technologies India earned net profit of ₹52.4 crore on revenue of ₹735 crore, against ₹194 crore on ₹1,824 crore for Rategain Travel Technologies. Capillary Technologies India's operating margin was 2.4% (Rategain Travel Technologies 14.1%).
From Capillary Technologies India's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.